Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lumexa Imaging HoldingsLMRI +4.48%9 6-1 Month Momentum % is -14.10% as of Aug. 13, 2026. GuruFocus rates LMRI with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 843 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 53.02% on this metric.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-08-13), Lumexa Imaging Holdings's 6-1 Month Momentum % is -14.10%.
The industry rank for Lumexa Imaging Holdings's 6-1 Month Momentum % or its related term are showing as below:
LMRI's 6-1 Month Momentum % is ranked worse than 53.02% of 843
companies
in the Medical Devices & Instruments industry
Industry Median: -12.74
vs LMRI: -14.10
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Lumexa Imaging Holdings 6-1 Month Momentum % Related Terms
LMRI vs QDEL, PRCT, AVNS: 6-1 Month Momentum % Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings 6-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a 6-1 Month Momentum % of -14.10% as of Aug. 13, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Lumexa Imaging Holdings and its competitors. According to the industry distribution chart, Lumexa Imaging Holdings ranks #447 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 53%.
Is Lumexa Imaging Holdings' 6-1 Month Momentum % too high?
Lumexa Imaging Holdings' current 6-1 Month Momentum % is -14.10%. Based on the distribution chart, Lumexa Imaging Holdings ranks #447 out of 843 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Lumexa Imaging Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' 6-1 Month Momentum % compare to QDEL and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #447 out of 843 companies for 6-1 Month Momentum %. This places Lumexa Imaging Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Medical Devices & Instruments company?
A good 6-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Lumexa Imaging Holdings and its competitors. Lumexa Imaging Holdings's current 6-1 Month Momentum % is -14.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current 6-1 Month Momentum % of -14.10%. The current 6-1 Month Momentum % is -14.10%. Lumexa Imaging Holdings' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current 6-1 Month Momentum % is -14.10% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
9GF Score
Get the complete analysis for LMRI
6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 
